Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung

European Journal of Immunology

Volumn 40, Issue 8, 2010, Pages 2200-2210

  Redford, Paul S ^a   Boonstra, Andre ^a,b   Read, Simon ^a,c   Pitt, Jonathan ^a   Graham, Christine ^a   Stavropoulos, Evangelos ^a   Bancroft, Gregory J ^d   O'Garra, Anne ^a  

^a Division of Immunoregulation   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NOVO NORDISK A S   (Denmark)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Granulocytes; IL 10; IL 17; Mycobacterium tuberculosis; Th1

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; IMMUNE RESPONSE; INFECTION CONTROL; LUNG; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SERUM; SPLEEN; TUBERCULOSIS;

ANIMALS; ANTIBODIES, BLOCKING; BACTERIAL LOAD; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL10; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; TH1-TH2 BALANCE; TUBERCULOSIS;

EID: 77955385939     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040433     Document Type: Article

References (56)

1. Cooper, A. M., Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 2009. 27: 393-422.
2. Flynn, J. L. and Chan, J., Immunology of tuberculosis. Annu. Rev. Immunol. 2001. 19: 93-129.
3. North, R. J. and Jung, Y. J., Immunity to tuberculosis. Annu. Rev. Immunol. 2004. 22: 599-623.
4. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G. and Orme, I. M., Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 1993. 178: 2243-2247.
5. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A. and Bloom, B. R., An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993. 178: 2249-2254.
6. Casanova, J. L. and Abel, L., Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 2002. 20: 581-620.
7. Chackerian, A. A., Perera, T. V. and Behar, S. M., Gamma interferonproducing CD4+T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 2001. 69: 2666-2674.
8. Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E. et al., IL-23 and IL-17 in the establishment of protective pulmonary CD4+T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007. 8: 369-377.
9. Lockhart, E., Green, A. M. and Flynn, J. L., IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 2006. 177: 4662-4669.
10. Aujla, S. J., Chan, Y. R., Zheng, M., Fei, M., Askew, D. J., Pociask, D. A., Reinhart, T. A. et al., IL-22 mediates mucosal host defense against Gramnegative bacterial pneumonia. Nat. Med. 2008. 14: 275-281.
11. Aujla, S. J., Dubin, P. J. and Kolls, J. K., Th17 cells and mucosal host defense. Semin. Immunol. 2007. 19: 377-382.
12. Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schreiber, R. et al., Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995. 2: 561-572.
13. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N. and Braun, M. M., Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 2001. 345: 1098-1104.
14. MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K. and Nathan, C. F., Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 1997. 94: 5243-5248.
15. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001. 19: 683-765.
16. O'Garra, A., Barrat, F. J., Castro, A. G., Vicari, A. and Hawrylowicz, C., Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 2008. 223: 114-131.
17. Gazzinelli, R. T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kuhn, R., Muller, W. et al., In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996. 157: 798-805.
18. Li, C., Corraliza, I. and Langhorne, J., A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi infection in mice. Infect. Immun. 1999. 67: 4435-4442.
19. Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C.,Wynn, T. A. and Sacks, D. L., The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 2001. 194: 1497-1506.
20. Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B. and Oldstone, M. B., Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006. 12: 1301-1309.
21. Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S. and von Herrath, M. G., Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 2006. 203: 2461-2472.
22. Silva, R. A. and Appelberg, R., Blocking the receptor for interleukin 10 protects mice from lethal listeriosis. Antimicrob. Agents Chemother. 2001. 45: 1312-1314.
23. Jung, Y. J., Ryan, L., LaCourse, R. and North, R. J., Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice. Immunology 2003. 109: 295-299.
24. Boussiotis, V. A., Tsai, E. Y., Yunis, E. J., Thim, S., Delgado, J. C., Dascher, C. C., Berezovskaya, A. et al., IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 2000. 105: 1317-1325.
25. Gerosa, F., Nisii, C., Righetti, S., Micciolo, R., Marchesini,M., Cazzadori, A. and Trinchieri, G., CD4(1) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 1999. 92: 224-234.
26. Gong, J. H., Zhang, M., Modlin, R. L., Linsley, P. S., Iyer, D., Lin, Y. and Barnes, P. F., Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 1996. 64: 913-918.
27. Verbon, A., Juffermans, N., Van Deventer, S. J., Speelman, P., Van Deutekom, H. and Van Der Poll, T., Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 1999. 115: 110-113.
28. Roach, D. R., Martin, E., Bean, A. G., Rennick, D. M., Briscoe, H. and Britton, W. J., Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand. J. Immunol. 2001. 54: 163-170.
29. Roque, S., Nobrega, C., Appelberg, R. and Correia-Neves, M., IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. J. Immunol. 2007. 178: 8028-8035.
30. Jacobs, M., Brown, N., Allie, N., Gulert, R. and Ryffel, B., Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 2000. 100: 494-501.
31. Murray, P. J. and Young, R. A., Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect. Immun. 1999. 67: 3087-3095.
32. Higgins, D. M., Sanchez-Campillo, J., Rosas-Taraco, A. G., Lee, E. J., Orme, I. M. and Gonzalez-Juarrero, M., Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2009. 89: 149-157.
33. North, R. J., Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 1998. 113: 55-58.
34. Beamer, G. L., Flaherty, D. K., Assogba, B. D., Stromberg, P., Gonzalez-Juarrero, M., de Waal Malefyt, R., Vesosky, B. and Turner, J., Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/Jmice. J. Immunol. 2008. 181: 5545-5550.
35. Turner, J., Gonzalez-Juarrero, M., Ellis, D. L., Basaraba, R. J., Kipnis, A., Orme, I. M. and Cooper, A. M., In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 2002. 169: 6343-6351.
36. Skold, M. and Behar, S. M., Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J. Immunol. 2008. 181: 6349-6360.
37. Wolf, A. J., Linas, B., Trevejo-Nunez, G. J., Kincaid, E., Tamura, T., Takatsu, K. and Ernst, J. D., Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 2007. 179: 2509-2519.
38. Bhatt, K., Hickman, S. P. and Salgame, P., Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J. Immunol. 2004. 172: 2748-2751.
39. Demangel, C., Bertolino, P. and Britton, W. J., Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur. J. Immunol. 2002. 32: 994-1002.
40. Humphreys, I. R., Stewart, G. R., Turner, D. J., Patel, J., Karamanou, D., Snelgrove, R. J. and Young, D. B., A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect. 2006. 8: 1339-1346.
41. Khader, S. A., Partida-Sanchez, S., Bell, G., Jelley-Gibbs, D. M., Swain, S., Pearl, J. E., Ghilardi, N. et al., Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 2006. 203: 1805-1815.
42. Chackerian, A. A., Alt, J. M., Perera, T. V., Dascher, C. C. and Behar, S. M., Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 2002. 70: 4501-4509.
43. Reiley, W. W., Calayag, M. D., Wittmer, S. T., Huntington, J. L., Pearl, J. E., Fountain, J. J., Martino, C. A. et al., ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc. Natl. Acad. Sci. USA 2008. 105: 10961-10966.
44. Wolf, A. J., Desvignes, L., Linas, B., Banaiee, N., Tamura, T., Takatsu, K. and Ernst, J. D., Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 2008. 205: 105-115.
45. Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P. et al., Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 2001. 194: 519-527.
46. Khan, I. A., MacLean, J. A., Lee, F. S., Casciotti, L., DeHaan, E., Schwartzman, J. D. and Luster, A. D., IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 2000. 12: 483-494.
47. Gonzalez-Juarrero, M., Hattle, J. M., Izzo, A., Junqueira-Kipnis, A. P., Shim, T. S., Trapnell, B. C. et al., Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukoc. Biol. 2005. 77: 914-922.
48. Abadie, V., Badell, E., Douillard, P., Ensergueix, D., Leenen, P. J., Tanguy, M., Fiette, L. et al., Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 2005. 106: 1843-1850.
49. Eum, S. Y., Kong, J. H., Hong, M. S., Lee, Y. J., Kim, J. H., Hwang, S. H., Cho, S. N. et al., Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary tuberculosis. Chest 2010. 137: 122-128.
50. Seiler, P., Aichele, P., Bandermann, S., Hauser, A. E., Lu, B., Gerard, N. P., Gerard, C. et al., Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur. J. Immunol. 2003. 33: 2676-2686.
51. Eruslanov, E. B., Lyadova, I. V., Kondratieva, T. K., Majorov, K. B., Scheglov, I. V., Orlova, M. O. and Apt, A. S., Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect. Immun. 2005. 73: 1744-1753.
52. Keller, C., Hoffmann, R., Lang, R., Brandau, S., Hermann, C. and Ehlers, S., Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect. Immun. 2006. 74: 4295-4309.
53. Barnes, P. F., Leedom, J. M., Chan, L. S.,Wong, S. F., Shah, J., Vachon, L. A., Overturf, G. D. and Modlin, R. L., Predictors of short-term prognosis in patients with pulmonary tuberculosis. J. Infect. Dis. 1988. 158: 366-371.
54. Bandara, A., Bremner, S., Barker, R. D., Packe, G., Griffiths, C. and Martineau, A., Neutrophilia in tuberculosis. Thorax 2008. 63: A114.
55. Zhang, X., Majlessi, L., Deriaud, E., Leclerc, C. and Lo-Man, R., Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 2009. 31: 761-771.
56. Shoemaker, J., Saraiva, M. and O'Garra, A., GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+T cells. J. Immunol. 2006. 176: 3470-3479.